Tag: diabetes

Healthcare

Rising patient numbers and novel products are set to drive growth in the Chinese antidiabetics market

Melbourne, March 23, 2011 – Driven by the growing diabetic population and the improved healthcare insurance coverage implemented as part of the country's 2009 healthcare reform, the value of the overall diabetes drugs market in China will triple from $0.7bn in 2009 to $2.1bn in 2019, according to a new report from independent market analyst,…

25 Mar 2011, by test test

Healthcare

The Australian reimbursement committee is set to consider Novo Nordisk’s type 2 diabetes treatment

Melbourne – 5th October 2010 - Novo Nordisk: swift approval of Victoza for reimbursement is vital to the drug's success. Lisette Oversteegen, Lead Analyst, comments: “For a prescription drug to be commercially successful in Australia, being included on the country's government reimbursement list, the Pharmaceutical Benefits Scheme (PBS) is essential”. In its November meeting, the…

5 Oct 2010, by test test